Clinical Trial

Early Inflammatory Bowel Disease Progression

Name: Early Inflammatory Bowel Disease Progression — clinical trial record (NCT06756100)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PRO-IBD

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess the capacity of the gut microbial composition and function to predict the course of IBD during the first year after diagnosis.

Trial Details

NCT Number	NCT06756100
Lead Sponsor	Pontificia Universidad Catolica de Chile Collaborators: Fondo Nacional de Desarrollo Científico y Tecnológico, Chile
Conditions	Inflammatory Bowel Diseases, Crohn Disease (CD), Ulcerative Colitis (UC)
Enrollment	140 participants
Start Date	2023-07-07
Primary Completion	2027-04 (estimated)
Study Completion	2027-04 (estimated)
Updated on ClinicalTrials.gov	2025-01-01